World’s 1st Flashlight Experience Store Kicks Off in Las Vegas
LAS VEGAS, Sept. 15, 2024 /PRNewswire/ — Olight, a brand committed to becoming a global leader in mid-to-high-end flashlights, opened the world’s first flashlight experience store at Fashion Show Las Vegas. On the same day, it hosted a major new product launch event and a fan festival
Statement by the Prime Minister on the International Day of Democracy
OTTAWA, ON, Sept. 15, 2024 /CNW/ – The Prime Minister, Justin Trudeau, today issued the following statement on the International Day of Democracy: “This year’s International Day of Democracy comes at a pivotal time. Rapidly evolving technologies are disrupting our way of life. Disi
ATA Celebrates America’s Professional Truck Drivers During National Truck Driver Appreciation Week
WASHINGTON, Sept. 15, 2024 /PRNewswire/ — Today, the American Trucking Associations marked the start of National Truck Driver Appreciation Week, an annual celebration recognizing the nation’s more than 3.5 million professional truck drivers. “The conveniences of modern life have in
Platform Science to Acquire Trimble’s Global Transportation Telematics Business Units to Drive the Future of Transportation In-Cab Technology
Partnership will Accelerate Global Expansion of Virtual Vehicle Trimble to Become a Shareholder in Platform Science’s Expanded Business WESTMINSTER, Colo. and SAN DIEGO, Sept. 15, 2024 /PRNewswire/ — Trimble (NASDAQ: TRMB) and Platform Science announced today they are partnering to trans
Kleo Teams Up with Londis to Enhance Convenience Store Operations with Advanced EPOS and MPOS Solutions
LONDON, Sept. 15, 2024 /PRNewswire/ — Kleo, a prominent provider of EPOS systems and self-ordering kiosks, is excited to announce a new partnership with Londis, one of the UK’s most recognised convenience store chains. This collaboration marks a significant step in modernising LondisR
ESMO 2024 – ImmVira Unveils Clinical Results of Intravesical MVR-T3011 for High-Risk BCG-Failure NMIBC Patients
SHENZHEN, China, Sept. 15, 2024 /PRNewswire/ — ImmVira announced the latest clinical results for its lead oncolytic virus product, MVR-T3011, via intravesical administration in patients with high-risk BCG-failure non-muscle invasive bladder cancer (NMIBC). The results were published through po
Luohu Explores Economic Opportunities in Europe, Strengthens Ties with Portugal
LIBSON, Portugal, Sept. 15, 2024 /PRNewswire/ — In a strategic move following a recent tour of the Asia-Pacific region, the Luohu District in Shenzhen, located in South China’s Guangdong Province, has dispatched a new delegation to Spain and Portugal, with a focus on exploring economic
New data from TAR-200 Phase 2b SunRISe-1 study show 84 percent complete response rate in patients with high-risk non-muscle-invasive bladder cancer
Investigational TAR-200 monotherapy demonstrates high complete response rate without the need for reinduction or additive therapy in patients who are Bacillus Calmette-Guérin (BCG)-unresponsive BARCELONA, Spain, Sept. 15, 2024 /PRNewswire/ — Johnson & Johnson (NYSE:JNJ) announced today
Akeso Published Ivonescimab plus Ligufalimab as First-Line Treatment for PD-L1-Positive Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma at ESMO 2024
Head-to-Head Phase 3 Trial Compared to Pembrolizumab Initiated HONG KONG, Sept. 15, 2024 /PRNewswire/ — At the 2024 European Society for Medical Oncology (ESMO) Conference, Akeso released the Phase 2 clinical results of its internally developed PD-1/VEGF bispecific antibody, ivonescimab, with
Akeso Published First-Ever Efficacy Data for PD-1/VEGF Bispecific Antibody Ivonescimab with or without CD47 Antibody plus FOLFOXIRI for mCRC at ESMO 2024
HONG KONG, Sept. 15, 2024 /PRNewswire/ — At the 2024 European Society for Medical Oncology (ESMO) Conference, Akeso (9926.HK) presented efficacy data for the first time for its internally developed PD-1/VEGF bispecific antibody, ivonescimab, with or without ligufalimab (anti-CD47 antibody AK1
